Breyanzi
breyanzihcp.com
Actively hiring
Oncology Therapeutics
Cell & Gene Therapy
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Omega Funds
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Omega Funds Similar startupsby what they do, their industry and backers
Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver…
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Unleashing unconventional antigens for cancer immunotherapy. Learn about our technology.
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.
Overview
BREYANZI® (lisocabtagene maraleucel) is a CD19-directed, genetically modified, autologous T-cell immunotherapy for adult patients with certain types of lymphoma. See response rates and safety profile. Please see Important Safety Information including Boxed WARNINGS.